Normal neuronal concentrations of all NOS-inhibiting-MA, were determined to be ≈15 µM, while L-arginine concentration is ≈90 µM. These MA levels result in >50% inhibition of NO generation from nNOS. Down-modulation or up-modulation of these neuronal MA levels, respectively, dramatically enhanced or suppressed NO-mediated excitotoxic injury. Thus, neuronal MA profoundly modulate NOS function and suppress NO mediated injury. Pharmacological modulation of the levels of these intrinsic NOS inhibitors offers a novel approach to modulate neuronal function and injury.
INTRODUCTION
The biological significance of guanidino-methylated arginine derivitives (MA) has been known since the inhibitory actions of N G -methyl-L-arginine (NMA) on macrophage induced cytotoxicity were first demonstrated (1) . It was subsequently realized that these effects were mediated through inhibition of NO release. This naturally occurring arginine analogue together with its structural congener asymmetric dimethylarginine (ADMA), form a pair of L-arginine derivatives with the ability to regulate the L-arginine:NO pathway (2) (3) (4) . While these MA are known to inhibit nitric oxide synthase (NOS) at pharmacological concentrations, questions remain regarding whether they have significant effects at their intrinsic cellular concentrations. It has been suggested that MA can modulate vascular function but there has been a lack of direct knowledge regarding cellular MA levels and how these modulate NO generation from NOS (2, (5) (6) (7) (8) . In addition, data demonstrating the importance of ADMA in disease pathophysiology are correlative, and there is no direct evidence that these arginine analogues modulate in vivo NO generation and NOS function.
Nitric oxide (NO) is a ubiquitous intracellular messenger synthesized from the guanidino group of L-arginine in a reaction catalyzed by nitric oxide synthase. It is involved in the control of vascular tone and blood pressure, platelet function, neurotransmission and host defense. In neurons, the NOS concentration and activity is relatively high and these cells are particularly sensitive to NO mediated injury through excitotoxicity and other diseases (9, 10) . Despite the importance of NO in the nervous system, there has been a lack of knowledge regarding the intracellular concentration of MA with no prior measurements in neurons. It is unknown if significant MA formation occurs in neurons and, in particular, if the levels of the critical NOS inhibiting MA, NMA or ADMA are sufficient to modulate NO production from nNOS.
ADMA and NMA are endogenously derived from the proteolysis of methylated arginine residues on various proteins (4) . The methylation is carried out by a group of enzymes referred to as protein-arginine methyl transferases (PRMT). Subsequent proteolysis of proteins containing methylarginine groups leads to the release of free methylarginine into the cytoplasm. Plasma NMA and ADMA enter the cell through the y + cationic amino acid transporter and these methylarginines compete with each other as well as with L-arginine for transport. It has been reported that plasma concentrations of ADMA and NMA are in the range of 0.5-1 µM (4). However, the levels of ADMA and NMA in neuronal tissue are not known. Interestingly, it is known that myelin basic protein, which is highly expressed in neuronal tissue, is a principal target of the PRMT 2 isoform.
In addition to the substrate specificity of PRMT 2, it also has specificity in its catalytic activity, with this myelin basic protein specific enzyme preferentially catalyzing the formation of NMA (4) .
With this in mind, one might postulate that nervous tissue may have relatively high levels of NMA, in addition to levels of ADMA also found in other tissues. Despite the apparent bioavailability of these inhibitors, little is known regarding their endogenous regulation of nNOS (11, 12) . Questions also remain regarding the exact extent of concentration dependent inhibition of NOS by MA. Considering the importance of NO in neuronal signaling and, when present in excess as a mediator of brain injury, it is of great importance to determine the levels of methylarginines and how they regulate neuronal NOS function.
To address these questions, we determine the concentrations of L-arginine and MA in brain tissue and in neurons. From measurements of initial rates of NO formation the kinetic parameters of substrate dependent NO formation and its inhibition by NMA and ADMA are determined. The dose dependent effects of MA on the inhibition of nNOS are characterized with measurements of the NOS products NO and L-citrulline. Both in isolated enzyme preparations and in primary cultured neurons it is determined that endogenous MA critically modulate the function of NOS.
This regulation is shown to be of critical importance in preventing NO-mediated neuronal injury.
EXPERIMENTAL PROCEDURES
nNOS Purification-Rat nNOS was purified from stable transfected human kidney 293 cells in a manner similar to that described previously (27) . These nNOS-transfected cells were grown in minimum essential medium with 10% heat inactivated fetal calf serum. Cells were then harvested and homogenized in 50 mM Tris-HCl (pH 7.4), containing 1.0 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 1.0 mM diethylenetriaminepentaacetic acid (DTPA) and 10 mM 2-mercaptoethanol with 1.0 mM phenylmethylsulfonyl fluoride (PMSF) and 2 µM leupeptin (buffer A). After centrifugation at 500 x g for 10 minutes at 4 0 C, the supernatant was loaded on a 2',5'-ADP Sepharose affinity column. After washing the column with 0.45 M NaCl, NOS was eluted with 50 mM Tris-HCl (pH 7.4) containing 10 mM NADPH and concentrated using Centricon-30 concentrators. Excess NADPH, DTPA and 2-mercaptoethanol were removed by repetitive washing and 40-fold concentration with 50 mM Tris-HCl (pH 7.4) containing 1.0 mM PMSF and 2 µM leupeptin. Concentrated enzyme was then stored at -80 0 C in this buffer with the addition of 10% glycerol. Protein content was assayed by the method of Bradford using bovine serum albumin as a standard. The purity of nNOS was greater than 95%
determined by sodium dodecylsulfate (SDS)-polyacrylamide gel electrophoresis as described previously (27) .
EPR spectroscopy and spin trapping-Spin-trapping measurements of NO were performed using a Bruker ER 300 spectrometer with Fe-MGD as the spin trap (13) . For enzyme studies, the reaction mixture consisted of 10 µg/ml purified nNOS in 50 mM Tris, pH 7. The reaction buffer was the same as described in the citrulline conversion assay except that NADPH was 200 µM, dithioerythritol (DTT) 150 µM and 2.5 µM oxyhemoglobin was added.
Fitting of experimental points for the rate measurements were performed using a best fit polynomial generated using Table Curve Equation (1
HPLC -Rat cerebellar granule cells were isolated and cultured as previously described and briefly detailed below (10, 20) . Cells were collected and sonicated in PBS followed by extraction using a cation exchange column (18) . Samples were derivatized with OPA and separated on a Toso Haas (Milford, MA) ODS-80Tm column (4.6mm X 25 cm i.d., 5 µm particle size) and arginine and methylarginines separated and detected using an ESA (Chelmsford, MA) HPLC system with electrochemical detection at 400mV. Homoarginine was added to the homogenate as an internal standard to correct for the efficiency of extraction (18) . The mobile phase consisted of 50 mM citrate buffer pH 6.2 -methanol-acetonitrile (900:80:150) run at room temperature with a flow rate of 1mL/min. Intracellular levels of arginine and methylarginines were determined from values derived from standard curves of each analyte using the ESA peak integration software followed by correction for dilution and cell volume (19) .
Cell Culture-Cerebellar granule cells were prepared from rat pups on postnatal day 7 as previously described with some modification (10, 20) . In brief, the cerebella from rat pups were dissected, 
RESULTS

Endogenous Levels of ADMA and L-NMMA in Neuronal Tissue-
To examine whether these MA NOS inhibitors are present in sufficient concentration to basally modulate NO production from nNOS, we developed a novel method for measuring their intrinsic levels based on electrochemical detection using cation exchange chromatography of derivatised amino acids. The intracellular concentrations of L-arginine and MA were determined in cerebellar granule neurons and brain tissue. Significant MA concentrations were detected with values of 11.1 ± 1.1 µM for NMA and 3.9 ± 0.6 µM for ADMA with L-arginine levels of 88.6 ± 6.5 µM in neurons ( fig. 1 ). In freshly isolated brain tissue (from rats), the levels of NMA, ADMA and L-arginine were similar to those measured in the neurons with values (mean ± SEM) of 10.7 ± 1.3 µM, 5.1 ± 0.6 µM and 94.0 ± 7.8 µM, respectively. When the cultured neurons were pretreated for 24 hours with the PRMT inhibitor, S-adenosylhomocysteine, a 53% decrease in NMA and 61% decrease in ADMA were observed ( fig. 1 ). These results show for the first time that neuronal cells have significant concentrations of endogenous MA and these levels can be modulated by regulation of PRMT.
Measurement of Kinetic Parameters of nNOS Inhibition-
In order to determine whether these endogenous MA levels should be sufficient to significantly inhibit NO production from nNOS we measured the precise kinetic parameters of the enzyme and the effects of ADMA and NMA on initial rates of NO production from nNOS.
Although the V max and K m of rat nNOS have been determined by several groups, questions and controversy remain regarding the apparent K i values for these MA NOS inhibitors. Previous studies have reported as would be expected that MA are competitive NOS inhibitors, but there is disagreement regarding the exact K i values (22) (23) (24) . For NMA values over the range 0.4-6.2 µM have been reported and there is little data available regarding ADMA (22) (23) (24) . Therefore, in order to be able to predict the effect of any given ADMA or NMA level on the initial rates of NO production from nNOS these kinetic studies were performed to measure initial rates of NO formation from nNOS as a function of L-arginine and ADMA or NMA levels using the oxyhemoglobin to methemoglobin conversion assay. The methemoglobin assay was used to measure these initial rates. The K m value was determined to be 2.38 µM with a V max of 0.229 µmol mg -1 min -1 ( fig. 2A) . The data obtained from the inhibitors ADMA and NMA were fitted with an equation for competitive inhibition and the K i values obtained were 0.672 µM and 0.501 µM, respectively ( fig. 2 B-C) .
Concentration Dependence of ADMA and NMA Mediated Inhibition of NO Production-
The kinetic data predicted that under physiological conditions these MA inhibitors should significantly inhibit the initial rates of NO formation from nNOS, but it is unclear if this effect is sustained over time. Because NOS activity is under negative feedback regulation with marked reduction in activity over time, it is important to evaluate the time dependent inhibitory actions of ADMA and NMA on NOS. Electron paramagnetic resonance (EPR) spin trapping measurements of NO were performed to determine the dose dependent inhibitory effects of NMA or ADMA on NO production over a 60 minute period. nNOS was purified from stably transfected human kidney 293 cells, incubated in the presence of physiological L-arginine levels (100 µM) and NO production directly measured using iron-N-methyl-D-glucamine dithiocarbamate (Fe-MGD) as the NO trap (15) . This EPR technique enables direct and definitive detection of NO generation from the enzyme. These experiments were performed using 15 N-guanidino L-arginine as substrate. 15 NO
gives a characteristic doublet 15 NO-Fe-MGD spectrum, rather than the triplet observed with natural abundance 14 NO, enabling direct and selective detection of L-arginine derived NO formation (14, 25) . From the observed spectra, both NMA and ADMA are seen to exhibit prominent dose dependent inhibition of nNOS in the presence of cellular L-arginine levels and this inhibition was sustained for over 30 minutes. NMA inhibited NO production by 26% at 10 µM concentration, with almost complete inhibition at 100 µM ( fig 3A) . These experiments were carried out in the presence of 100 µM L-arginine, supporting previous reports that these MA have a higher affinity than the native substrate L-arginine (4). With ADMA the results were comparable, with 23% inhibition at 10 µM and almost complete inhibition at 100 µM ( fig. 3B ). Thus, both methylarginines exert similar sustained inhibition of NO production from nNOS.
Effects of Endogenous Levels of Methylarginines and Substrate on NO Production from nNOS-
From the concentration dependent inhibition of nNOS above, we observe that sustained inhibition of NO production occurs even at low MA concentrations with clear inhibition seen at levels as low as 10 µM in the presence of 100 µM L-arginine. In order to more precisely determine the effects of the physiological levels of methylarginines and L-arginine on nNOS mediated NO generation experiments were performed measuring NO from nNOS in the presence of physiological levels of either MA alone or together. The time course and relative magnitude of NO production from nNOS in the presence of L-arginine (90 µM), with or without ADMA (5 µM) and NMA (10 µM) was determined. From this data, it is seen that over a 30 minute period that both ADMA and NMA inhibited the rate and total production of NO from the enzyme ( fig. 4A-B ).
When present together, ADMA and NMA inhibited NO production by greater than 50%. This indicates that under basal conditions these endogenous methylarginines should exert an important sustained inhibitory influence on NO production in neurons.
In order to further verify these observations and quantitation of the effects of these inhibitors on enzyme activity, measurements of the formation of the L-arginine derived NOS product L-citrulline were performed. Inhibition of this measured enzyme activity was seen paralleling the EPR data with >50% inhibition seen in the presence of both inhibitors (fig 4.C) .
Thus, both EPR measurements of NO and citrulline assay of NOS activity demonstrate that endogenous levels of MA exert prominent inhibition of nNOS function that is sustained over time.
Effects of ADMA and NMA on NO Production and Excitotoxic Injury in Neurons-
In order to further verify that these inhibitors do in fact suppress NO formation in neurons, intact primary cultured cerebellar granule cells were subjected to excitotoxic injury and NO levels measured by EPR. Since excitotoxic injury, as induced by NMDA, is largely mediated through excess production of NO, neurons were stimulated with NMDA (50 µM) and NO production was 1 ) and a two-fold increase in NO production was seen ( fig. 5B ). This data confirms that the endogenous methylarginine levels inhibit NO generation from nNOS in neurons. When NMA or ADMA (100 µM) were added, intracellular levels of these methylarginines rose from 11.1 ± 1.1 µM for NMA and 3.9 ± 0.6 µM for ADMA to 19.7±4.9 µM and 29.6±5.2 µM, respectively.
NMDA stimulated NO production was markedly inhibited with more than a 2-fold decrease seen Finally, parallel studies were performed to assess if modulation of NO by endogenous NMA and ADMA confers neuroprotection against NMDA induced neurotoxicity ( fig. 5C ).
Neurons were exposed to 50 µM NMDA for thirty minutes and then returned to normal media for 24 hours. Subsequently, cell viability was assessed by both trypan blue exclusion and MTT assay.
Both viability measurements demonstrated that cellular injury mirrored NO production. NMDA treatment resulted in death of 20% of the cells, 24 hour pretreatment with Sadenosylhomocysteine, which has been shown to deplete intracellular MA (26) , caused exacerbation of toxicity with almost 2-fold increase in cell death. This NMDA mediated cell death was reduced in the presence of both ADMA and NMA. Pretreatment with either 100 µM ADMA or NMA resulted in marked protection. NMA had slightly less neuroprotective effects, which might be expected if one considers that NOS itself can release superoxide which is not inhibitable by NMA but is by ADMA (27) .
DISCUSSION
While NO is formed in neurons and is a critical mediator of neuronal signaling, at high levels it can induce neuronal injury. It is well known that NO is synthesized by the L-arginine dependent enzyme nNOS, however, questions remain regarding the processes that regulate the activity of this critical enzyme. While methylarginines can exert competitive inhibition of the NOS isoforms, it was unknown if the levels of the endogenous MA, NMA and ADMA, are sufficient to exert inhibition of nNOS and if the levels of these compounds regulate NO formation from NOS and protect against neuronal injury. Therefore in the current study we measured the levels of MA in the brain and in neuronal cells and then determined the effects of these levels on nNOS function.
We directly measured the dose dependent inhibition of NO formation from nNOS by NMA and ADMA and in kinetic studies and determined the K i of each of these inhibitors enabling the prediction of the extent of inhibition for any level of inhibitor. Furthermore, we observe in neurons that the intrinsic levels of MA modulate NO production and prevent excitotoxic injury.
With a novel method for measuring MA levels based on electrochemical detection using 
B-C).
Electron paramagnetic resonance (EPR) measurements of 15 NO formation from 15 N guanidino L-arginine were performed to further elucidate the dose dependent inhibitory effects of NMA or ADMA on NO production from nNOS and to determine whether the endogenous MA levels are sufficient to exert sustained inhibition of NO production. While from the K i values measured it would be predicted that there would be inhibition of initial rates, in view of the controversy over the physiological effects of these intrinsic inhibitors, it is critically important to determine if this effect is sustained over time. Since NOS is regulated by feedback inhibition secondary to NO binding to the heme and this process could be altered by the methyl-arginines that bind in proximity to the heme, it is essential to perform a definitive measurement of NO formation over time. Both NMA and ADMA exhibited prominent dose dependent inhibition of NO formation from nNOS in the presence of cellular L-arginine levels and this inhibition was sustained over time. NMA and ADMA exerted partial inhibition of NO production at 10 µM concentration, with almost complete inhibition at 100 µM (fig 3) . To precisely determine the effects of the physiological levels of methylarginines and L-arginine on nNOS mediated NO generation, experiments were performed in the presence of the physiological MA levels. Both ADMA and NMA inhibited the rate and total production of NO from the enzyme ( fig. 4A-B) .
When present together, the physiological ADMA and NMA levels inhibited NO production by greater than 50%. This indicates that under basal conditions these endogenous methylarginines exert an important inhibitory influence on NO production in neurons. To confirm these observations and rule out any possible alteration or perturbation caused by trapping NO by either hemoglobin or the EPR spin trap Fe-MGD, these observations were further confirmed with measurements of the formation of the NOS product L-citrulline, where again >50% inhibition was seen in the presence of the physiological levels of both inhibitors (fig 4.C) . Thus, it was observed that endogenous levels of MA exert prominent inhibition of nNOS function and this inhibition is sustained over time.
The levels of endogenous methylarginines present in neurons were thus shown to be sufficient to modulate the function of nNOS. In addition to the experiments with purified nNOS, we sought to determine whether these inhibitory actions of ADMA and NMA could be observed in primary neuronal cells. Exposure of cerebellar granule cells to NMDA has been shown to generate NO resulting in cellular injury (9) . We observed that pretreatment with ADMA or NMA decreases NO production and ameliorates NO mediated injury. Furthermore, pretreatment of the cells with SAHC, a PRMT inhibitor, resulted in depletion of intracellular MA with increased NO production and increased cell injury following NMDA exposure. Taken together these results demonstrate that the endogenous MA pool is capable of modulating NO production and may play a critical role in regulating NOS function.
Because of the prominent inhibition that ADMA and NMA offer, and the potential for these concentrations to further rise following cellular injury with proteolysis, it will be important to study their involvement in a variety of pathological conditions associated with nNOS activation. In addition to regulating basal NO production, these endogenous NOS inhibitors may also provide a critical feedback mechanism to protect the brain against a vicious cycle whereby excess NOS activation and NO production from injured neurons would otherwise lead to uncontrolled expanded injury of neighboring neurons. Since pharmacological modulation of NMA and ADMA production by SAHC resulted in a prominent change in NO production and secondary cytotoxicity, therapeutic agents that target the production and metabolism of these endogenous inhibitors would be expected to be particularly useful in modulating neuronal function and protecting against neuronal injury.
The data presented suggests that PRMT may play a critical role in modulating NO production through its regulation of the methylarginine pool. This may be of significant importance when considering pathological conditions, such as stroke, where excess NO production is involved. In fact, it has recently been shown that following ischemic injury in the urethra, MA levels are raised with subsequent impairment of smooth muscle relaxation resulting from MA mediated NOS inhibition (28) . This MA regulatory cascade may represent a novel pathway whereby the cell can suppress excess NO production and minimize NO mediated cellular injury.
However, one must also consider the role of dimethylarginine dimethylaminohydrolase, DDAH, the enzyme responsible for the metabolism of MA, in controlling MA bioavailability. DDAH catalyzes the conversion of both NMA and ADMA to L-citrulline. DDAH has been shown to be expressed in neuronal tissue and may play an important role in regulating NOS function through its effects on MA. It has been reported that two isoforms of DDAH exist (DDAH I and DDAH II) in human tissues, it appears that DDAH I predominates in tissues expressing nNOS while DDAH II is observed in eNOS expressing tissues (4).
In conclusion, these results provide the first direct evidence regarding the importance of MA levels in the brain and their involvement as modulators of NOS function and NO production under both normal and pathological conditions. These results also demonstrate the need for future studies, to address how the MA regulatory enzymes, DDAH and PRMT, function to regulate intrinsic MA levels, under both normal and pathological conditions. 
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